Conteduca, V., Wetterskog, D., Sharabiani, M., Grande, E., Fernandez-Perez, M., Jayaram, A., . . . Attard, G. (2017). Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study.
Citación estilo ChicagoConteduca, V., et al. Androgen Receptor Gene Status in Plasma DNA Associates With Worse Outcome On Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study. 2017.
Cita MLAConteduca, V., et al. Androgen Receptor Gene Status in Plasma DNA Associates With Worse Outcome On Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study. 2017.